Lewis A Tetrasaccharide - a key glycobiological probe to unlock precision medicine

Lewis A Tetrasaccharide (Leᵃ) is a crucial glycosylated antigen on cell surface glycoproteins and glycolipids, known as the "cell identity messenger." It is not only a key regulator in development and cell communication, but also an indispensable core tool molecule in modern biomedicine, especially in the fields of cancer diagnosis, immunotherapy and drug development.

Basic product information

Chemical name: Lewis A Tetrasaccharide

Common name: Leᵃ antigen, CD15L

Chemical formula: C₂₆H₄₅NO₂₀

Molecular weight: 691.63 g/mol

CAS number: 117660-09-0

Structural characteristics and biological significance

Lewis A Tetrasaccharide has an exquisite and unique structure, which is the basis for its biological functions:

Precise tetrasaccharide sequence: Its structure consists of fucose, galactose, N-acetylglucosamine and another galactose connected by specific α-1,4 and β-1,3 bonds. This precise sequence is its "molecular fingerprint" recognized by specific antibodies or lectins.

The "hub" of cell interaction: As an important component of cell surface glycans, Leᵃ is directly involved in the adhesion, recognition and signal transduction processes between cells, and is one of the chemical languages ​​​​for cells to "dialogue".

Important antigenic determinant: This structure is a precise target for a variety of monoclonal antibodies, such as anti-Leᵃ, making it an ideal molecule for immune detection and targeted therapy development.

Main applications and core values

1. Core tools for cancer research and biomarker development

Tumor diagnosis and classification: Leᵃ antigen is specifically and highly expressed in a variety of cancer tissues (such as gastrointestinal cancer, pancreatic cancer, lung cancer, etc.) and is an important tumor-related antigen. Leᵃ is a key raw material for the development of immunohistochemical detection reagents, ELISA kits and liquid biopsy technology, facilitating the early detection and accurate classification of cancer.

Prognosis assessment: The expression level of Leᵃ is closely related to the malignancy of the tumor, metastasis potential and patient prognosis, and is a highly valuable prognostic biomarker.

2. The cornerstone of drug development and targeted therapy

Targets of antibody drugs and ADCs: Monoclonal antibodies developed against the Leᵃ antigen can be directly used to construct antibody drug conjugates (ADCs) to achieve precise delivery of small molecule toxins, effectively kill tumor cells while reducing systemic side effects.

Vaccine development: Anti-cancer vaccines based on Leᵃ can train the patient's own immune system to specifically recognize and eliminate tumor cells expressing this antigen, opening up new paths for immunotherapy.

Drug screening and validation: Leᵃ can be used to screen and validate lead compounds that can block cell adhesion or signaling pathways mediated by them, providing a platform for the development of new small molecule inhibitors.

3. Basic research and development of diagnostic tools

Study on the mechanism of glycobiology: Leᵃ plays an important role in physiological processes such as fertilization, embryonic development and inflammatory response. It is a standard reference and key reagent for studying its biosynthesis, function and regulatory mechanism.

Test standards and controls: As standards with clear molecular structures and extremely high purity, they are widely used in the quality control, calibration and methodology development of diagnostic reagents to ensure the accuracy and reliability of test results.

Conclusion

Lewis A Tetrasaccharide is more than just a sugar chain molecule, it is a bridge connecting basic research and clinical applications. From the precise diagnosis of cancer to the development of targeted drugs, from revealing the mysteries of life to promoting treatment innovation, its value has become increasingly prominent.